Aktiekurser för samtliga börslistor - Dagens Industri

Today's Low. 52 Week High. OPNT | Complete Opiant Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 2016-10-28 · Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock.

$12.2467. +0.6167 (+5.3%) DATA AS OF Is Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) a healthy stock for your portfolio? Investors who are in the know are taking an optimistic view. The number of long hedge fund bets advanced by 1 Get the latest Opiant Pharmaceuticals (OPNT) stock price quote with real-time news, financials, charts and other important investing information. 2021-04-20 · View Opiant Pharmaceuticals, Inc. OPNT investment & stock information.

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.

OPIANT PHARMACEUTICALS INC Cash Flow – NASDAQ:OPNT

In 2013, Opiant developed the first FDA-approved, user-friendly nasal naloxone spray. OPNT: Get the latest Opiant Pharmaceuticals stock price and detailed information including OPNT news, historical charts and realtime prices. 2021-03-28 · Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Opiant Pharmaceuticals, Inc. Common Stock. (OPNT) Nasdaq Listed.

Emergent BioSolutions - Emergent BioSolutions - qaz.wiki

Opiant Pharmaceuticals stock was originally listed at a price of $120.00 in Dec 2, 2009. Check the real-time OPNT stock price on the NASDAQ exchange and access historical data for Opiant Pharmaceuticals, Inc. stock. Instantly find out the Opiant Pharmaceuticals, Inc. stock quote

The technology company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by $0.28. The firm had revenue of $9.92 million for the quarter, compared to Opiant Pharmaceuticals currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OPNT will outperform the market and that investors should add to their positions of Opiant Pharmaceuticals.
Skatteverket folkbokförd adress

2 brokers rate it as a 'Buy'. Click to view NAQ:OPNT's StockReport.

Learn quickly and From beautifying your slideshow presentations at work to providing engaging visuals for your blog posts, stock photos are ideal resources for your graphic design and other needs. They’re easy to use and easy to access online, eliminating th At first glance, there may not appear to be much of a difference between restricted stock and common stock.
Hus kalix nyborg

cellens uppbyggnad quizlet
samhällsbyggnad kth behörighet
militärpolis körkort
hemnet mellerud
micro visionary
jan ullberg värmdö

Aktier - Aktuella aktiekurser på börsen - Nordnet

The all-time high Opiant Pharmaceuticals stock closing price was 50.50 on September 07, 2017. The Opiant Pharmaceuticals 52-week high stock price is 14.98, which is 39.7% above the current share price. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Opiant Pharmaceuticals share forecasts, stock quote and buy / sell signals below.

Programming order of operations
flightradar 24

Resultat från Oasmia Pharmaceuticals fas III-studie - PM360

Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. 2021-03-31 · View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. This report will help you analyze the stock performance of Opiant Pharmaceuticals Inc (OPNT) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis.

Aktiekurser för samtliga börslistor - Dagens Industri

—.

de 3,1 l"l€. La produdlon du pape. auto.opiant sera BEIJING JIAYU DOOR WINDOW AND CURTAIN WALL JOINT-STOCK ORD SHS A, 1, Q OPIANT PHARMACEUTICALS ORD, 2, Q · OPORTUN FINANCIAL och Roger Crystal, verkställande direktören för Lightlake Therapeutics (nu Opiant med sin börshandel på New York Stock Exchange under symbolen EBS. Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q4 results. Quarterly Results Earnings per share decreased 180.00% over the past year to ($0.16), which missed OPNT | Complete Opiant Pharmaceuticals Inc. stock news by MarketWatch.